Clinical trial
A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis.
NCT03174587 is registered in ClinicalTrials.gov with Corestemchemon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis.
- Lead sponsor
- Corestemchemon, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 30, 2017
- Completion date
- August 19, 2019
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.